Impower133 Trial Demonstrates Immunotherapy in Small Cell Lung Cancer

As reported in Cure Today by Brielle Urciulo, Small Cell Lung Cancer (SCLC) is a disease that has spread too far for surgery or radiation therapy to be useful for initial treatment and therefore, chemotherapy has been the standard of care. However the Impower133 trial is showing that immunotherapy is showing progress in the treatment of extensive-stage SCLC. See the link for a summary of study here.